Bai-Lin Zhang

Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer

Yi Yin, Pin Zhang, Bing-He Xu, Bai-Lin Zhang +6 more

2013Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2 citations

Semantic Scholar

Bai-Lin Zhang

Most-cited papers

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer

Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial

Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer.

Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the U.S.

A Feasibility Study of the Intraductal Administration of Chemotherapy

A novel non-invasive exhaled breath biopsy for the diagnosis and screening of breast cancer

Trends in Radical Surgical Treatment Methods for Breast Malignancies in China: A Multicenter 10-Year Retrospective Study.

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

MiR-3653 blocks autophagy to inhibit epithelial–mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1

Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea

Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective study.

The safety parameters of the study on intraductal cytotoxic agent delivery to the breast before mastectomy.

Prognostic factors of primary neuroendocrine breast cancer: A population‐based study

Abstract P3-14-07: Carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer - A phase II clinical trial

Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer

Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

[Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].

Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population‐based study from China

Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer

[Comparison of touch imprint cytology of core needle biopsy and section histopathology in breast cancer diagnosis].

[Morphologic assessment of response to neoadjuvant chemotherapy in breast cancer].

[Diagnostic value of core needle biopsy before neoadjuvant chemotherapy for breast cancer].

Abstract PS13-23: Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: A population-based study using the SEER 18 database

Effect of BRWD3 on lymph node metastasis in breast cancer

Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes

[Association study of genetic variations in SLCO1B3 gene with prognosis in breast cancer patients treated with neoadjuvant chemotherapy of TA regimen].

Abstract P1-15-07: Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea: A prospective study in China

[Impact of stages of axillary lymph nodes and pathological response to neoadjuvant chemotherapy on the survival of breast cancer patients].

Diagnostic value of X-ray stereotactic vacuum-assisted biopsy for breast micro-calcification

Core needle biopsy for the diagnosis of breast tumor

Abstract LB-245: Local drug delivery to the breast: A Phase I study of breast intraductal cytotoxic agent administration prior to mastectomy

Mammary ductoscopy for the diagnosis of intraductal lesions in patients concomitant with pathologic nipple discharge